worldwide offices | contact | help | sitemap

 

 

 

 

Newsroom

Newsroom

PrinttextDecrease text sizeIncrease text size

Media releases

Welcome to the Novartis Vaccines press room. You can find copies of our latest press releases, Novartis Vaccines links, contact information and general details about the Novartis Vaccines business unit. Our team of international communications professionals is always available to help meet the information needs of the news media around the world. We hope that you find these materials useful and encourage you to contact us directly if further details are required. Thank you for your interest in Novartis Vaccines.

For further information please do not hesitate to contact us.


2010

2009

2008

2007

2006

29-Jul-2010

Novartis Vaccines begins shipment of seasonal influenza vaccine Fluvirin® to U.S. market to help protect ahead of 2010-2011 flu season

 

 

31-Mar-2010

UK Media Release: New vaccine can protect travellers against four types of meningitis

 

 

18-Mar-2010

Novartis receives approval in the European Union for Menveo®, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease

 

 

22-Feb-2010

Novartis receives FDA approval of Menveo®, a vaccine to prevent meningococcal disease

 

 

20-Jan-2010

Novartis Receives Regulatory Approval in Japan for Celtura®, a Cell Culture-Based Influenza A(H1N1) 2009 Pandemic Vaccine

 

Back to top

Influenza

influenza

Learn out how the influenza vaccine is created.

Learn more about influenza vaccines

Corporate Citizenship

Corporate citizenship

Corporate citizenship rests on four pillars: patients, business conduct, people & communities, environmental care.

Read more on the four pillars